DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Mephedrone is an investigational drug.
There have been 3 clinical trials for Mephedrone. The most recent clinical trial was a Phase 1 trial, which was initiated on January 30th 2020.
The most common disease conditions in clinical trials are Amphetamine-Related Disorders, Disease, and Alcohol-Related Disorders. The leading clinical trial sponsors are Instituto de Salud Carlos III, Parc de Salut Mar, and Fundacio Lluita Contra la SIDA.
Recent Clinical Trials for Mephedrone
|Clinical Trial to Evaluate Pharmacological Interactions Between γ-hydroxybutyrate (GHB) and Cobicistat||Fundacio Lluita Contra la SIDA||Phase 1|
|Mephedrone and Alcohol Interactions in Humans||Instituto de Salud Carlos III||Phase 1|
|Mephedrone and Alcohol Interactions in Humans||Parc de Salut Mar||Phase 1|